About PocDoc
PocDoc is a UK-based health technology company revolutionising point-of-care diagnostics through smartphone-enabled blood testing. The company has developed an app-based technology platform that combines proprietary Microfluidic Assay (MFA) technology with cloud-based AI diagnostics to deliver end-to-end digital pathways for the assessment, diagnosis and treatment of Cardio, Metabolic and Renal (CMR) diseases. Their flagship product, the Healthy Heart Check, provides fully quantified lab-grade lipid panel results in under 10 minutes from a simple finger-prick blood test. The platform delivers a complete 5-marker cholesterol panel including Total Cholesterol, HDL, Non-HDL/LDL, Triglycerides, and Total Cholesterol/HDL ratio, along with Heart Age and 10-year cardiovascular disease risk calculations compared against NHS clinical guidelines. PocDoc offers solutions for both healthcare professionals (PocDoc Pro) and individual consumers, with the professional version integrating with electronic health records and clinical risk engines. The company's mission is to prevent millions of premature deaths by identifying those at highest risk of CMR diseases, addressing the critical access gap where millions of at-risk individuals have never been tested. Founded by a multidisciplinary team of scientists, entrepreneurs and healthcare professionals, PocDoc is working to make diagnostics accessible for all, particularly those at highest risk who face barriers to traditional testing.
Mission & Story
Mission
We are on a mission to prevent millions of premature deaths by identifying those at highest risk of Cardio, Metabolic and Renal (CMR) diseases.
Founding Story
The company was founded in response to widening health inequalities and access issues in healthcare. The founders pondered the question of how to make it easier for patients to undergo blood tests and facilitate screening, particularly as many at-risk individuals are turned away from doctors due to resource limitations. Their answer was to leverage the ubiquity and image analysis capabilities of smartphones, designing an accessible test that harnesses phone image analysis capabilities combined with cloud computing.
Clinical Focus
Medical conditions and clinical areas addressed by PocDoc.
Who It Serves
Milestones & Awards
Recent Milestones
CEO Steve Roest is member of UK Research and Innovation Future Leaders review board. Multiple Innovate UK grant awards received.
Awards & Recognition
Multiple Innovate UK grant awards. CEO serves on UK Research and Innovation Future Leaders review board.
Key Partnerships
Company Details
- Headquarters
- Cambridge, England, United Kingdom
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.